A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition that will affect one in 37 people in Britain in their lifetime. A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition that will affect one in 37 people in Britain in their lifetime.
Ozempic-like jab ‘fails’ for millions who suffer age-related condition, study finds
